AUCKLAND, Thursday: Authority PR has forged a strategic relationship with NZ’s Covid-19 Vaccine Corporation. CVC ceo Dr Robert Feldman said: “We propose a unique approach to the development of a vaccine utilising New Zealand biobead technology.
“CVC already has strategic partnerships with University of Auckland, Ardigen, and Callaghan Innovation.
“I am absolutely delighted with the partnership with Authority PR.
“Our executive team concentrate on our vaccine development so this partnership will significantly enhance our ability to communicate our progress to all interested parties.
“Authority PR was founded by former journalist and communications practitioner Golnaz Bassam-Tabar in 2018.”
Authority PR director Golnaz Bassam-Tabar said: “Our partnership is founded on our strategic vision to align ourselves with innovative Kiwi businesses who pave the way to find solutions and add value, especially one with the potential to change millions of lives.
“It is generally agreed that an effective vaccine is the only realistic approach to permanently lifting lockdown and mitigation strategies. There is no vaccine technology that is guaranteed to succeed and with the current unknowns about the virus, as things stand, any approach may or may not succeed.
“CVC is set up by a group of Kiwis experts in pharmaceutical and biotechnology fields with specialisations in vaccine development and production.”
Authority PR was founded by former journalist and communications practitioner Golnaz Bassam-Tabar in 2018 with a portfolio spanning corporate, FMCG, tech and hospitality clients.
Share this Post